Trial Profile
Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine: Results From an 8-week, Multicenter, Double-blind, Placebo-controlled Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jul 2023
Price :
$35
*
At a glance
- Drugs Lamotrigine (Primary)
- Indications Bipolar II disorders
- Focus Therapeutic Use
- 15 Dec 2016 New trial record